![Christoph Broja](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christoph Broja
Directeur/Membre du Conseil chez
Cardior Pharmaceuticals GmbH
Profil
Mr. Christoph Broja, CFA, is a Partner at EQT Life Sciences (Munich).
He is on the Board of Directors at Cardior Pharmaceuticals GmbH.
Mr. Broja was previously employed as a Board Member by Tremeau Pharmaceuticals, Inc., a Principal by Gurnet Point Capital LLC, and a Senior Analyst by Franz Haniel & Cie.
GmbH.
He received his undergraduate degree from Friedrich Schiller University of Jena.
Postes actifs de Christoph Broja
| Sociétés | Poste | Début |
|---|---|---|
Cardior Pharmaceuticals GmbH
 Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts | Directeur/Membre du Conseil | 01/09/2022 |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Private Equity Investor | 01/09/2022 |
Anciens postes connus de Christoph Broja
| Sociétés | Poste | Fin |
|---|---|---|
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Analyste en capital-investissement | 01/03/2021 |
Tremeau Pharmaceuticals, Inc.
 Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers non-opioid pain therapies for people | Directeur/Membre du Conseil | 01/06/2022 |
Franz Haniel & Cie. GmbH
 Franz Haniel & Cie. GmbH Investment ManagersFinance Haniel is an active manager that seeks to invest in diversified established sustainable companies, but it also provides growth and earlier stage capital for companies in development stages. | Analyste en capital-investissement | 01/07/2012 |
Formation de Christoph Broja
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Finance |
Franz Haniel & Cie. GmbH
Franz Haniel & Cie. GmbH Investment ManagersFinance Haniel is an active manager that seeks to invest in diversified established sustainable companies, but it also provides growth and earlier stage capital for companies in development stages. | Finance |
Friedrich Schiller University of Jena
 Friedrich Schiller University of Jena Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Finance |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts | Health Technology |
Tremeau Pharmaceuticals, Inc.
Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers non-opioid pain therapies for people | Health Technology |
